Spatial and temporal patterns of pharmaceuticals in the aquatic environment: A review

Geography Compass

Volumn 2, Issue 3, 2008, Pages 920-955

  Stamm, C ^a   Alder, A C ^a   Fenner, K ^a,b   Hollender, J ^a   Krauss, M ^a   McArdell, C S ^a   Ort, C ^a   Schneider, M K ^a,c  

^a SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^b SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^c AGROSCOPE RECKENHOLZ TÄNIKON RESEARCH STATION ART   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54349089277     PISSN: None     EISSN: 17498198     Source Type: Journal    
DOI: 10.1111/j.1749-8198.2008.00104.x     Document Type: Article

References (131)

1. Alder, A. C., et al. (2006). Consumption and occurrence. In: Ternes, T. A. and Joss, A. (eds) Human pharmaceuticals, hormones and fragrances: the challenges of micropollutants in urban water management. London: IWA, pp. 15-54.
2. Allan, I. J., et al. (2006). A 'toolbox' for biological and chemical monitoring requirements for the European Union's Water Framework Directive. Talanta 69, pp. 302-322.
3. Andreozzi, R., Raffaele, M., and Nicklas, P. (2003). Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50, pp. 1319-1330.
4. Arnold, S., et al. (2004). Banning antimicrobial growth promoters in feedstuffs does not result in increased therapeutic use of antibiotics in medicated feed in pig farming. Pharmacoepidemiology and Drug Safety 13, pp. 323-331.
5. Beven, K., and Freer, J. (2001). Equifinality, data assimilation, and uncertainty estimation in mechanistic modelling of complex environmental systems using the GLUE methodology. Journal of Hydrology 249, pp. 11-29.
6. Boreen, A. L., Arnold, W. A., and Mcneill, K. (2003). Photodegradationof pharmaceuticals in the aquatic environment: a review. Aquatic Sciences 65, pp. 320-341.
7. Brauch, H.-J., Fleig, M., and Sacher, F. (2006). Vorkommen und Bewertung von Arzneimittelrückständen in Rhein und Main. Veröffentlichungen aus dem Technologiezentrum Wasser Karlsruhe. Karlsruhe, DVGW-Technologiezentrum Wasser (TZW). Breton, R., and Boxall, A. B. A. (2003). Pharmaceuticals and personal care products in the environment: regulatory drivers and research needs. QSAR & Combinatorial Sciences 22, pp. 399-409.
8. Brian, J. V., et al. (2005). Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environmental Health Perspectives 113, pp. 721-728.
9. Burkhardt, M., et al. (2005). Surface runoff and transport behaviour of sulfonamides and tracers after manure application on grassland. Journal of Environmental Quality 34, pp. 1363-1371.
10. Buser, H. R., Poiger, T., and Müller, M. D. (1998). Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environmental Science and Technology 32, pp. 3449-3456.
11. Buser, H. R., Poiger, T., and Müller, M. D. (1999). Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environmental Science and Technology 33, pp. 2529-2535.
12. Chen, C.-F., Ma, H.-W., and Reckhow, K. H. (2007). Assessment of water quality management with a systematic qualitative uncertainty analysis. Science of the Total Environment 374, pp. 13-25.
13. Clara, M., Strenn, B., and Kreuzinger, N. (2004). Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Research 38, pp. 947-954.
14. Commission of the European Communities. (2000). Proposal of the European Parliament and of the council for a directive on environmental quality standards in the field of water policy and amending Directive 2000/60/EC; COM(2006) 398 final. D'Ascenzo, G., et al. (2003). Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Science of the Total Environment 302, pp. 199-209.
15. Daughton, C. G. (2003). Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rational for and avenues towards a Green Pharmacy. Environmental Health Perspectives 111, pp. 757-774.
16. Daughton, C. G. (2004). PPCPs in the environment: future research beginning with the end always in mind. In: Kümmerer, K. (ed.) Pharmaceuticals in the environment, 2nd ed., New York: Springer, pp. 463-495.
17. Daughton, C. G., and Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: agents of subtle change? Environmental Health Perspectives 107, pp. 907-938.
18. Davis, J. G., et al. (2006). Antibiotic transport via runoff and soil loss. Journal of Environmental Quality 35, pp. 2250-2260.
19. Drewes, J. E., et al. (2003). Fate of pharmaceuticals during ground water recharge. Ground Water Monitoring and Remediation 23, pp. 64-72.
20. Dubus, I. G., Brown, C. D., and Beulke, S. (2003). Sources of uncertainty in pesticide modelling. The Science of the Total Environment 317, pp. 53-72.
21. Escher, B. I., et al. (2005). Screening test battery for pharmaceuticals in urine and wastewater. Environmental Toxicology and Chemistry 24, pp. 750-758.
22. Escher, B. I., et al. (2006). Comparative ecotoxicological hazard assessment of beta-Blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environmental Science & Technology 40, pp. 7402-7408.
23. European Commission. (2007). 2007/322/EC: commission Decision of 4 May 2007 laying down protective measures concerning uses of plant protection products containing tolylfluanid leading to the contamination of
24. European Medicines Agency. (2006). Guideline on the environmental risk assessment of medicinal products for human use. London: Committee for Medicinal Products for Human Use (CHMP); EMEA.
25. European Parliament (2007). Compromise amendments 1-3: proposal for a Directive of the European Parliament and of the Council on environmental quality standards in the field of water policy and amending Directive 2000/60/EC (PE 378.719v01-00).
26. European Commission. (2007). Guideline on environmental impact assessment for veterinary medicinal products in support of the VICH guidelines GL6 and GL38. London: Committee for Medicinal Products for Veterinary Use (CVMP); EMEA.
27. Federal Office for the Environment. (2007). Micropollutants. [online]. Retrieved on March 19, 2008 from http://www.bafu.admin.ch/gewaesserschutz/03716/index.html?lang=en
28. Figueroa, R. A., Leonard, A., and Mackay, A. A. (2004). Modeling tetracycline antibiotic sorption to clays. Environmental Science & Technology 38, pp. 476-483.
29. Figueroa, R. A., and Mackay, A. A. (2005). Sorption of oxytetracycline to iron oxides and iron oxide-rich soils. Environmental Science & Technology 39, pp. 6664-6671.
30. Filippini, M., Masiero, G., and Moschetti, K. (2006). Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 78, pp. 77-92.
31. FOCUS (2000). FOCUS groundwater scenarios in the EU review of active substances. Brussels, Belgium: Groundwater Working Group of FOCUS.
32. FOCUS (2001). FOCUS surface water scenarios in the EU evaluation process under 91/414/EEC. Brussels, Belgium: FOCUS Working Group on Surface Waters.
33. Fono, L. J., Kolodziej, E. P., and Sedlak, D. L. (2006). Attenuation of wastewater-derived contaminants in an effluent-dominated river. Environmental Science and Technology 40, pp. 7257-7262.
34. Göbel, A., et al. (2005a). Extraction and determination of sulfonamides, macrolides, and trimethoprim in sewage sludge. Journal of Chromatography A 1085, pp. 179-189.
35. Göbel, A., et al. (2005b). Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environmental Science & Technology 39, pp. 3981-3989.
36. Göbel, A., et al. (2007). Fate of sulfonamides, macrolides and trimethoprim in different wastewater treatment technologies. Science of the Total Environment 372, pp. 361-371.
37. Golet, E. M., et al. (2003). Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environmental Science and Technology 37, pp. 3234-3249.
38. Gros, M., Petrovic, M., and Barceló, D. (2006). Multi-residue analytical methods using LCtandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Analytical and Bioanalytical Chemistry V386, pp. 941-952.
39. Halling-Sörensen, B., et al. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere 36, pp. 357-394.
40. Hao, C., Clement, R., and Yang, P. (2007). Liquid chromatography-tandem mass spectrometry of bioactive pharmaceutical compounds in the aquatic environment - a decade's activities. Analytical and Bioanalytical Chemistry 387, pp. 1247-1257.
41. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters 131, pp. 5-17.
42. Hernandez, F., et al. (2005). Strategies for quantification and confirmation of multi-class polar pesticides and transformation products in water by LC-MS2 using triple quadrupole and hybrid quadrupole time-of-flight analyzers. TrAC: Trends in Analytical Chemistry 24, pp. 596-612.
43. Hollender, J., Singer, H., and Fenner, K. (2006). Combination of linear ion trap with Orbitrap technology to detect and identify metabolites in environmental water samples. In: 2nd Int. Workshop Liq. Chromatogr.-Tandem Mass Spectrom. Screening Trace Level Quantitation Environ. Food Samples. Barcelona, Spain. Holm, J. V., et al. (1995). Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environmental Science and Technology 29, pp. 1415-1420.
44. Huang, W. L., et al. (2003). Effects of organic matter heterogeneity on sorption and desorption of organic contaminants by soils and sediments. Applied Geochemistry 18, pp. 955-972.
45. Huber, M. M., et al. (2005). Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environmental Science and Technology 39, pp. 4290-4299.
46. Hummel, D., et al. (2006). Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environmental Science and Technology 40, pp. 7321-7328.
47. Hutson, J. L. (2003). Leaching estimation and chemistry model. Model description and user's guide. Adelaide, Australia: The Flinders University of South Australia.
48. International Federation of Animal Health. (2005). Facts and figures about the European Animal Health Industry. Brussels, Belgium: IFAH-Europe, representing the European Animal Health Industry. [online]. Retrieved on March 19, 2008 from http://www.ifahsec.org/Europe/publications/Facts%20and%20figures%20about%20the%20European%20Animal%20Health%20industry.pdf
49. Jahnel, J., et al. (2006). Scientific risk assessment of considered water relevant substances. Acta Hydrochimica et Hydrobiologica 34, pp. 389-397.
50. Jones, O. A. H., et al. (2007). Questioning the excessive use of advanced treatment to remove organic micropollutants from wastewater. Environmental Science & Technology 41, pp. 5085-5089.
51. Joss, A., et al. (2005). Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research 39, pp. 3139-3152.
52. Joss, A., et al. (2006). Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Research 40, pp. 1686-1696.
53. Jury, W. A., Focht, D. D., and Farmer, W. J. (1987). Evaluation of pesticide groundwater pollution potential from standard indices of soil-chemical adsorption and biodegradation. Journal of Environmental Quality 16, pp. 422-428.
54. Kahle, M., and Stamm, C. (2007). Sorption of the veterinary antimicrobial sulfathiazole to organic materials of different origin. Environmental Science & Technology 41, pp. 132-138.
55. Keller, V. (2006). Risk assessment of 'down-the-drain' chemicals: search for a suitable model. Science of the Total Environment 360, pp. 305-318.
56. Kellogg, R. L., and Lander, C. H. (1999). Trends in the potential for nutrient loading from confined livestock operations. Washington, DC: USDA-NRCS, US Gov. Print. Office.
57. Khetan, S. K., and Collins, T. J. (2007). Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. Chemical Reviews 107, pp. 2319-2364; DOI: 10.1021/cr020441w
58. Kim, S. C., and Carlson, K. (2007). Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environmental Science & Technology 41, pp. 50-57.
59. Klammler, H., et al. (2007). Initial test results for a passive surface water fluxmeter to measure cumulative water and solute mass fluxes. Environmental Science & Technology 41, pp. 2485-2490.
60. Kolpin, D. W., et al. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environmental Science & Technology 36, pp. 1202-1211.
61. Kools, S. A. E., Moltmann, J. F., and Knacke, T. (2008). Estimating the use of veterinary medicines in the European Union. Regulatory Toxicology and Pharmacology 50, pp. 59-65.
62. Kreuzig, R., and Höltge, S. (2005). Investigations on the fate of sulfadiazine in manured soil: laboratory experiments and test plot studies. Environmental Toxicology and Chemistry 24, pp. 771-776.
63. Kümmerer, K. (2004). Pharmaceuticals in the environment: Sources, fate, effects and risks. Berlin, Germany: Springer-Verlag.
64. Labadie, P., and Budzinski, H. (2005). Determination of steroidal hormone profiles along the Jalle d'Eysines River (near Bordeaux, France). Environmental Science & Technology 39, pp. 5113-5120.
65. Lai, K. M., et al. (2000). Binding of waterborne steroid estrogens to solid phases in river and estuarine systems. Environmental Science and Technology 34, pp. 3890-3894.
66. Larsbo, M., et al. (forthcoming). Simulating sulfadimidine transport in surface runoff and soil at the micro-plot and field scale. Journal of Environmental Quality.
67. Larson, S. J., Capel, P. D., and Majewski, M. S. (1997). Pesticides in surface waters. Chelsea, MI: Ann Arbor Press.
68. Leu, C., et al. (2004). Simultaneous assessment of sources, processes, and factors influencing herbicide losses to surface waters in a small agricultural catchment. Environmental Science and Technology 38, pp. 3827-3834.
69. Leu, C., et al. (2005). Comparison of atrazine losses in three small headwater catchments. Journal of Environmental Quality 34, pp. 1873-1882.
70. Lienert, J., Güdel, K., and Escher, B. I. (2007). Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes Environmental Science & Technology 41, pp. 4471-4478.
71. Loraine, G. A., and Pettigrove, M. E. (2006). Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environmental Science & Technology 40, pp. 687-695.
72. LUA (1999). Tierarzneimittel in der Umwelt: Erhebung von Tierarzneimittelmengen im Land Brandenburg für den Zeitraum von Juli 1998 bis Juni 1999. Potsdam, Germany: Landesumweltamt Brandenburg.
73. Luthy, R. G., et al. (1997). Sequestration of hydrophobic organic contaminants by geosorbents. Environmental Science & Technology 31, pp. 3341-3347.
74. Mackay, N., Mason, P., and Di Guardo, A. (2005). VetCalc exposure modelling tool for veterinary medicines. London: Defra Research Project VM02133.
75. McArdell, C. S., et al. (2003). Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed, Switzerland. Environmental Science & Technology 37, pp. 5479-5486.
76. McArdell, C. S., et al. (2006). Analytical methods. In: Ternes, T. A. and Joss, A. (eds) Human pharmaceuticals, hormones, and fragrances. The challenge of micropollutants in urban water management. London: IWA Publishing.
77. McIntyre, N. R., and Wheater, H. S. (2004). A tool for risk-based management of surface water quality. Environmental Modelling & Software 19, pp. 1131-1140.
78. Miao, X. S., Yang, J. J., and Metcalfe, C. D. (2005). Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environmental Science and Technology 39, pp. 7469-7475.
79. Montforts, M. (2006). Validation of the exposure assessment for veterinary medicinal products. Science of the Total Environment 358, pp. 121-136.
80. Motheral, B., et al. (2002). Express Scripts Prescription Drug Atlas: A Study of Geographic Variation in the Use of Prescription Drugs. Maryland Heights, MO: Express Scripts Inc.
81. Nash, J. P., et al. (2004). Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environmental Health Perspectives 112, pp. 1725-1733.
82. National Center for Health Statistics. (2004). Health, United States, 2004: with chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics.
83. Nesatyy, V. J., and Suter, M. J. F. (2007). Proteomics for the analysis of environmental stress responses in organisms. Environmental Science & Technology 41, pp. 6891-6900.
84. Nguyen, T. H., Goss, K. U., and Ball, W. P. (2005). Polyparameter linear free energy relationships for estimating the equilibrium partition of organic compounds between water and the natural organic matter in soils and sediments. Environmental Science & Technology 39, pp. 913-924.
85. Nikolaou, A., Meric, S., and Fatta, D. (2007). Occurrence patterns of pharmaceuticals in water and wastewater environments. Analytical and Bioanalytical Chemistry 387, pp. 1225-1234.
86. Ollers, S., et al. (2001). Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/1 level in surface and waste water. Journal of Chromatography A 911, pp. 225-234.
87. Ort, C. H. S., et al. (2007). Nationales Stoffflussmodell-Mikroverunreinigungen aus Abwasserreinigungsanlagen. Gas Wasser Abwasser 87, pp. 853-859.
88. Pomati, F., et al. (2006). Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environmental Science & Technology 40, pp. 2442-2447.
89. Qian, S. S., and Reckhow, K. H. (2007). Combining model results and monitoring data for water quality assessment. Environmental Science & Technology 41, pp. 5008-5013.
90. Reddersen, K., and Heberer, T. (2003). Multi-compound methods for the detection of pharmaceutical residues in various waters applying solid phase extraction (SPE) and gas chromatography with mass spectrometric (GC-MS) detection. Journal of Separation Science 26, pp. 1443-1450.
91. Reddersen, K., Heberer, T., and Dunnbier, U. (2002). Identification and significance of phenazone drugs and their metabolites in ground and drinking water. Chemosphere 49, pp. 539-544.
92. Report of the Joint Committee on the Use of Antibiotics in Animal Husbandry and Veterinary Medicine (1969). London: HM Stationary Office.
93. Rice, S. L., and Mitra, S. (2007). Microwave-assisted solvent extraction of solid matrices and subsequent detection of pharmaceuticals and personal care products (PPCPs) using gas chromatography-mass spectrometry. Analytica Chimica Acta 589, pp. 125-132.
94. Robinson, P. F., et al. (2007). Modeling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers. Chemosphere 66, pp. 757-766.
95. Rutsch, M., Rieckermann, J., and Krebs, P. (2006). Quantification of sewer leakage: a review. Water Science and Technology 54, pp. 135-144.
96. Rutt, G. (2004). A summary of investigations of sheep dip pollution in Southwest Wales 2002-2004. Bristol, UK: Environment Agency.
97. Sacher, F., et al. (2001). Pharmaceuticals in groundwaters-Analytical methods and results of a monitoring program in Baden-Württemberg, Germany. Journal of Chromatography A 938, pp. 199-210.
98. Sarmah, A. K., Meyer, M. T., and Boxall, A. B. A. (2006). A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65, pp. 725-759.
99. Sassman, S. A., and Lee, L. S. (2005). Sorption of three tetracyclines by several soils: assessing the role of pH and cation exchange. Environmental Science & Technology 39, pp. 7452-7459.
100. Scheytt, T. J., et al. (2007). Tracing pharmaceuticals in the unsaturated zone. Journal of Soils and Sediments 7, pp. 75-84.
101. Schneider, M., Stamm, C., and Fenner, K. (2007). Selecting scenarios to assess exposure of surface waters to veterinary medicines in Europe. Environmental Science & Technology 41, pp. 4669-4676.
102. Scottish Environment Protection Agency, Environmen Agency, and Veterinary Medicines Directorate. (2006). Public notice: use of cypermethrin sheep dip products following the suspension of their marketing authorisations.
103. Sedlak, D., Pinkston, K., and Huang, C. H. (2005). Occurrence survey of pharmaceutically active compounds. Denver, CO: Awwa Research Foundation.
104. Sinclair, C. J., et al. (2007). Cypermethrin losses from sheep farms CSL Project N3LT. York, UK: Central Science Laboratory.
105. Stamm, C., et al. (2002). Multiple tracing of fast transport in a drained grassland soil. Geoderma 109, pp. 245-268.
106. Steimen, I. (2006). Occurrence of sulfonamide antibiotics in manure and fertilised soils of selected Swiss farms. Umweltnaturwissenschaften. Zurich, Switzerland: ETH Zurich.
107. Stenemo, F., et al. (2007). Meta-modeling of the pesticide fate model MACRO for groundwater exposure assessments using artificial neural networks. Journal of Contaminant Hydrology 93, pp. 270-283.
108. Stockholm County Council (2005). Environmentally classified pharmaceuticals. Stockholm, Sweden: Miljöavdelningen, Department of the Environment.
109. Stoob, K., et al. (2006). Exhaustive extraction of sulfonamide antibiotics from aged agricultural soils using pressurized liquid extraction. Journal of Chromatography A 1128, pp. 1-9.
110. Stoob, K., et al. (2007). Dissipation and transport of veterinary sulfonamides after manure application to grassland in a small catchment. Environmental Science and Technology 41, 7349-7355.
111. Sumpter, J. P. (2007). Environmental effects of human pharmaceuticals. Drug Information Journal 41, pp. 143-147.
112. Ternes, T. A. (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Research 32, pp. 3245-3260.
113. Ternes, T. A., and Hirsch, R. (2000). Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment. Environmental Science and Technology 34, pp. 2741-2748.
114. Ternes, T. A., and Joss, A. (eds) (2006). Human pharmaceuticals, hormones, and fragrances: the challenge of micropollutants in urban water management. London, UK: IWA Publishing.
115. Ternes, T. A., et al. (2003). Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Research 37, pp. 1976-1982.
116. Ternes, T. A., et al. (2007). Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances. Chemosphere 66, pp. 894-904.
117. Ternes, T. A., Joss, A., and Siegrist, H. (2004). Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology 38, pp. 392A-399A.
118. Thiele-Bruhn, S. (2003). Pharmaceutical antibiotic compounds in soils-a review. Journal of Plant Nutrition and Soil Science 166, pp. 145-167.
119. Thiele-Bruhn, S., et al. (2004). Sorption of sulfonamide pharmaceutical antibiotics on whole soils and particle-size fractions. Journal of Environmental Quality 33, pp. 1331-1342.
120. Tixier, C., et al. (2003). Occurrence and fate of carbamazepine, ibuprofen, ketoprofen, and naproxen in surface waters. Environmental Science and Technology 37, pp. 1061-1068.
121. Umweltbundesamt (2007). Umweltrisikoabschätzung von Tierarzneimitteln: Gibt es Datenlücken und wie können die neuen gesetzlichen Anforderungen erfüllt werden? UBA FKZ 20567445; ECT Oekotoxikologie Flörsheim und Central Science Laboratory, University of York.
122. US Food and Drug Administration. (1998). Guidance for Industry: Environmental Assessment of Human Drug and Biologics Applications. US Department of Health and Human Services; Food and Drug Administration.
123. Vermeirssen, E. L. T., et al. (2005). Characterization of environmental estrogens in river water using a three pronged approach: active and passive water sampling and the analysis of accumulated estrogens in the bile of caged fish. Environmental Science and Technology 39, pp. 8191-8198.
124. VICH. (2000). VICH-GL6. Environmental impact assessment (EIAS) for veterinary medicinal products (VMPs) - Phase I Guidance. Brussels, Belgium: VICH International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products.
125. VICH. (2004). VICH-GL38. Environmental impact assessment (EIAS) for veterinary medicinal products - Phase II Guidance. Brussels, Belgium: VICH International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products.
126. Vieno, N. M., Tuhkanen, T., and Kronberg, L. (2005). Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environmental Science & Technology 39, pp. 8220-8226.
127. Vrana, B., et al. (2005). Passive sampling techniques for monitoring pollutants in water. TrAC: Trends in Analytical Chemistry 24, pp. 845-868.
128. Wang, Q., Guo, M., and Yates, S. R. (2006). Degradation kinetics of manure-derived sulfadimethoxine in amended soil. Journal of Agricultural and Food Chemistry 54, pp. 157-163.
129. Wauchope, R. D., et al. (2002). Pesticide soil sorption parameters: theory, measurement, uses, limitations and reliability. Pest Management Science 58, pp. 419-445.
130. Wehrhan, A., et al. (2007). Transport of sulfadiazine in soil columns-Experiments and modelling approaches. Journal of Contaminant Hydrology 89, pp. 107-135.
131. Westerhoff, P., et al. (2005). Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environmental Science and Technology 39, pp. 6649-6663.